Acetylmuramyl-Alanyl-Isoglutamine

dipeptidase 1 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 24370054 [Activation of NOD2 signalling pathway stimulates the function of human dendritic cells loaded with leukemia cell lysates]. 2013 Dec 1
2 23258559 Adjuvant effect of microencapsulated NOD ligands studied in a human phagocytic cell line. 2012 1
3 14679402 Experimental study of the pathogenesis of moyamoya disease: histological changes in the arterial wall caused by immunological reactions in monkeys. 2003 Oct 1
4 10936509 Endotoxin and muramyl dipeptide modulate surface receptor expression on human mononuclear cells. 2000 Jul 20 1
5 8405175 Recurrent anterior uveitis induced by multiple systemic injections of muramyl dipeptide. 1993 Jul 1
6 3125614 [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use]. 1987 Nov-Dec 1
7 3527628 New developments in the field of synthetic muramyl peptides, especially as adjuvants for synthetic vaccines. 1986 1
8 6332794 Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine. 1984 1
9 6358804 Muramyl peptides as possible endogenous immunopharmacological mediators. 1983 1
10 7296716 Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2. 1981 Jun 1
11 669885 Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine). 1978 Apr 2
12 701793 Absence of binding of MDP, a synthetic immunoadjuvant, to anti-peptidoglycan antibodies. 1978 Oct 2
13 985477 Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomers. 1976 Sep 7 1